Kerstin Papenfuss
Directeur/Membre du Conseil chez Deep Science Ventures Ltd.
Profil
Kerstin started her PhD at German Cancer Research Centre and then moved to a lab at Imperial College to work on novel treatment options within the field of tumour immunology.
She since has spent almost ten years in leadership roles at impact-driven organisations advancing medicine and therapeutics, while also securing an executive MBA and a women in business award.
Before joining DSV to develop science companies designing more effective personalised therapies, Kerstin was transforming ideas for cutting edge cell and gene therapies into investable propositions at UK’s Cell and Gene Therapy Catapult.
Postes actifs de Kerstin Papenfuss
| Sociétés | Poste | Début |
|---|---|---|
Deep Science Ventures Ltd.
 Deep Science Ventures Ltd. Investment ManagersFinance Deep Science Ventures Ltd. (Deep Science Ventures) is a venture capital firm founded 2016 by Mark Hammond and Dominic Falcão. The firm is headquartered in Essex, United Kingdom. | Directeur/Membre du Conseil | 01/11/2019 |
Antiverse Ltd.
 Antiverse Ltd. Internet Software/ServicesTechnology Services Antiverse Ltd. is building a world-first computational antibody drug discovery platform. It specializes in machine learning, antibodies, and drug discovery. The company was founded by Murat Tunaboylu, Rowina Westermeier and Ben Holla Holland and is headquartered in Cardiff, the United Kindom. | Directeur/Membre du Conseil | 01/11/2020 |
Anciens postes connus de Kerstin Papenfuss
| Sociétés | Poste | Fin |
|---|---|---|
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 30/06/2018 |
Formation de Kerstin Papenfuss
| Imperial College London | Doctorate Degree |
| Bayes Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Commercial Services |
Deep Science Ventures Ltd.
Deep Science Ventures Ltd. Investment ManagersFinance Deep Science Ventures Ltd. (Deep Science Ventures) is a venture capital firm founded 2016 by Mark Hammond and Dominic Falcão. The firm is headquartered in Essex, United Kingdom. | Finance |
Antiverse Ltd.
Antiverse Ltd. Internet Software/ServicesTechnology Services Antiverse Ltd. is building a world-first computational antibody drug discovery platform. It specializes in machine learning, antibodies, and drug discovery. The company was founded by Murat Tunaboylu, Rowina Westermeier and Ben Holla Holland and is headquartered in Cardiff, the United Kindom. | Technology Services |
